EP2260795A2 - Devices for repairing aneurysms - Google Patents
Devices for repairing aneurysms Download PDFInfo
- Publication number
- EP2260795A2 EP2260795A2 EP10011024A EP10011024A EP2260795A2 EP 2260795 A2 EP2260795 A2 EP 2260795A2 EP 10011024 A EP10011024 A EP 10011024A EP 10011024 A EP10011024 A EP 10011024A EP 2260795 A2 EP2260795 A2 EP 2260795A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- inner graft
- graft tube
- aneurysm
- tube
- graft
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/94—Stents retaining their form, i.e. not being deformable, after placement in the predetermined place
- A61F2/945—Stents retaining their form, i.e. not being deformable, after placement in the predetermined place hardenable, e.g. stents formed in situ
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/077—Stent-grafts having means to fill the space between stent-graft and aneurysm wall, e.g. a sleeve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
Definitions
- This invention concerns devices for use in repairing aneurysms, especially of the abdominal aorta.
- An aneurysm occurs when an arterial wall becomes weakened to the extent that the weakened section balloons under pressure from the blood flowing through the artery. An aneurysm can lead to fatality if it ruptures causing rapid loss of blood.
- An aortic aneurysm can be repaired by an endovascular repair procedure, in which a graft is inserted into the aneurysm via the femoral artery effectively to take the blood flow and to isolate the aneurysm.
- aortic endograft There are three forms of aortic endograft in current usage.
- the first is a straight stented tube graft. This may be used when there are adequate proximal and distal aortic necks for graft implantation.
- the tube may be stented at each end for support and to provide pins or hooks for embedding into the arterial wall to secure the tube in place.
- the tube may be stented throughout its length, such as by means of a metal wire stent. This form of endograft is used most commonly to repair aneurysms of the thoracic aorta.
- graft is a bifurcated tube for use in a patient with an abdominal aortic aneurysm where there is inadequate distal aortic neck but appropriate iliac artery configurations.
- the third variation of endovascular graft is an aortouniliac graft, in which the tube extends from the proximal aortic neck into one of the iliac arteries.
- an extraanatomic femofemoral bypass graft with a contralateral occlusion device in the common iliac artery is required.
- This device may be used when significant aneurismal disease is present in the contralateral iliac artery, precluding successful bifurcated graft placement.
- a problem with such grafts is that over time, even over a period of two years, the graft can slip due to wear and tear on the stents, the effect of pulsatile blood flow through the tube and changes in the morphology of the arteries.
- the blood flow effect can be exaggerated as the graft slips and is able to bend and flex.
- the integrity of the graft and isolation of the aneurysm can be compromised.
- Another problem with stented grafts is that the twisting or flexing of the graft can cause fatigue in the metal stent. Such fatigue leads to fracturing of the stent wire and the resultant wire ends can pierce the graft material. Holes in the graft material mean that the aneurysm is no longer isolated from the blood flow.
- Such grafts are generally used in a planned manner with the graft being selected for a specific patient according to precise pre-operative measurement of the aorta and adjacent arteries. Therefore, such grafts are not readily suited for use in repairing a ruptured aneurysm, where an emergency procedure is required simply to prevent death.
- An object of this invention is to provide a device for use in repairing aneurysms that does not suffer from the above-mentioned disadvantages.
- a device for repairing an aneurysm by deployment within the aneurysm comprising a graft tube, at least part thereof having an inflatable wall, whereby the tube can be deployed in an artery and be inflated to contact at least part of the arterial wall.
- arterial wall may include arterial wall that is undamaged and/or aneurysm wall.
- Graft tubes of the invention may be made of any suitable biologically compatible material and especially of plastics material.
- Graft devices of the invention may be straight tubes or bifurcated tubes for use depending on the position and size of the aneurysm, i.e. for deployment in a similar manner to conventional endograft graft tubes.
- the graft tube of this embodiment may be one that narrows from one end to the other for use in aortouniliac grafting.
- the device of the invention may have an inflatable wall along its entire length or the device may have one or more discrete inflatable sections, especially at one or more ends of the tube.
- the inflatable wall of the graft tube has an inner wall and an outer wall that is expandable in preference to the inner wall.
- the inner wall may be reinforced compared to the outer wall. Reinforcements of the inner wall may be, for example, by means of hoops, cages or mesh. Reinforcements may be of metal or plastics. Suitable metal reinforcement materials include stainless steel and nickel-titanium alloy. Suitable plastics reinforcement materials include inert polymers, such as, for example, polytetrafluoroethylene.
- the inner wall may be of a different material to the outer wall or may be of the same material but of different thickness to achieve the desired effect of the outer wall expanding upon inflation in preference to the inner wall with the inner wall substantially retaining its shape.
- the inflatable wall of the tube is preferably inflated by insertion of a settable material.
- the material is introduced as a liquid and sets to a solid or semi-solid state.
- the inflating material used will be biologically compatible and may, for example, be based on collagen or temperature/pH sensitive hydrogels, such as N-isopropyl acrylamide. It is possible that for stented graft tubes the inflating material need only set to a pliable condition. However, if the graft tube of the invention is to be deployed using a balloon to prevent an un-reinforced inner wall collapsing while the inflatable wall is being inflated, the inflating material may need to set to a relatively rigid condition.
- the tube may be deployed in an aneurysm by inflating the tube, so that at least at the proximal artery position and ideally also at the distal artery position the tube grips the walls of the artery where there is no wall damage and between those positions the outer wall of the tube expands to contact the walls of the aneurysm and thereby support the aneurysm against flexing.
- a graft tube for use in repairing arterial aneurysms may have a first part with an inflatable wall to fit into the neck of the artery above an aneurysm.
- the remainder of the graft can be a straight, tapered or bifurcated tube.
- Grafts of the invention may be deployed in an aortic aneurysm by means of conventional endovascular techniques.
- a guide wire is inserted through the femoral artery to extend beyond the aneurysm and the graft is guided into position along the wire.
- a narrow tube for inflating the twin walled part of the graft will be incorporated into the graft, one end of which will be accessible for the purpose of injection within the access wound in the groin. Once inflated to a desired extent the inflation tube is sealed.
- a graft according to the invention may be deployed with the aid of an inflatable deployment balloon.
- a graft of the invention may be positioned in an aneurysm in collapsed form mounted on a deflated deployment balloon.
- the deployment balloon can then be inflated to seal the graft to the arterial wall above and below the aneurysm before the outer part of the graft is inflated by means of the settable material to conform to the anatomy of the aneurysm. Finally, the deployment balloon is deflated and withdrawn.
- a tubular graft 10 is shown deployed in an aortic aneurysm 12.
- the aneurysm is situated between proximal and distal regions 14,16 respectively of the aorta 18. This deployment is possible when there is adequate aortic tissue above and below the aneurysm for attachment of the graft.
- the graft is stented (20,22) at each end and has pins 24 extending from the stented regions for attachment to the aortic wall.
- a bifurcated graft 30 can be used as shown in Figure 2 .
- the graft is attached in the neck 32 of the aorta above the aneurysm 34 and the two tubes 36 resulting from the bifurcation are each deployed in an iliac artery 38 below the aneurysm.
- the ends of the graft are stented (40) and pins 42 are provided to aid attachment to the artery walls.
- a graft 50 as shown in Figure 3 may be used, which is deployed between the aorta 52 above the aneurysm 54 and the healthier iliac artery 56.
- the graft tube 50 narrows to compensate for the difference in widths of the aorta and iliac artery.
- an extraanatomic femofemoral bypass 58 is required with a contralateral occlusion device 60 in the common iliac artery 62. Again this graft 50 is stented at both ends (64,66).
- FIG. 4 there is shown a tubular endovascular graft 100 of the invention for use in repairing an aortic aneurysm.
- the graft 100 is twin-walled having an inner wall 102 and an outer wall 104, whereby the space 105 between the walls can be inflated by introduction of inflating material.
- the outer wall 104 is relatively expandable compared to the inner wall 102. Both walls may be of the same material but the inner wall reinforced, so that upon inflation, the outer wall expands to contact the aneurysm wall, as shown in Figure 5 , whilst the inner wall 102 retains substantially its diameter, so as not to affect adversely blood flow through the graft.
- the inner wall 102 as shown is reinforced with metal hoops 106, although the reinforcement can be of other materials or take a different form. An alternative may be to make the inner and outer walls of different materials to achieve a similar effect.
- the graft 100 can be deployed in a similar manner to the graft shown in Figure 1 , i.e. between proximal and distal regions 110,112 respectively of the aorta 114 above and below the aneurysm 116.
- the graft When in position the graft is inflated by introduction of inflating material. This causes the outer wall of the graft to expand, firstly to grip the walls of the artery in those proximal and distal regions to fix the graft in place and secondly to contact the walls of the aneurysm to provide support therefor and, in the case of rupture, to seal the leakage of blood by direct closure of the tear in the aneurysm wall.
- the inflating material is preferably a biocompatible material and may, for example, be based on collagen or temperature/pH sensitive hydrogels, such as N-isopropyl acrylamide.
- the inflating material is one that can be introduced as a liquid but which sets to form a pliable mass, such as in the nature of a gel. Once sufficient inflating material is introduced into the graft, possibly through a valve, the inflated graft is sealed.
- a bifurcated graft 120 is shown which is similar in nature and general use to the graft 100 of Figures 4 and 5 but for the type of situation shown in Figure 2 of the drawings, i.e. where there is aortic tissue damage requiring iliac artery deployment.
- FIG. 7 of the accompanying drawings there is shown an alternative form of inflatable tubular graft 150.
- the graft shown is a bifurcated graft but only a top portion 152 thereof is twin-walled.
- the graft 150 can be deployed and the top portion 152 inflated as with other embodiments of the invention to fix the graft in the proximal neck 154 of the aorta 156 above the aneurysm 158.
- the iliac tubes 160,162 of the graft may be fixed in the iliac arteries 164,166 in a conventional manner.
- an endograft 200 comprises an inner graft tube 202 and an outer inflatable balloon 204 attached to the inner tube.
- the endograft shown is bifurcated but it could also be a single stem straight or tapered endograft.
- the outer balloon is designed to be inflated to conform to the anatomy of an aneurysm.
- the endograft 200 is delivered into aorta 206 in a collapsed state mounted over an inflatable deployment balloon 208.
- the deployment balloon is inflated to expand the graft to form seals at the anastomoses 210, 212 and 214 of the aorta and iliac arteries (see Figure 9 ).
- the outer balloon 204 of the endograft is inflated with a substance that rapidly sets to form a solid mass 216. Once that substance has set, the deployment balloon is deflated and removed, leaving the endograft supported by the inflated outer balloon that has conformed to the contours of the aneurysm sac 218.
- Fixation of the endograft can then be enhanced by placement of stents (with or without barbs or hooks), which secure the upper and lower extremities of the graft to the surrounding arterial wall.
- grafts according to the invention include the possibility of rapid deployment, which, in the case of a ruptured aneurysm is vital, because the graft does not have to be designed for a particular patient.
- the ability to inflate the graft to fix it in place means that the same type of graft can be used in a variety of cases.
- the gel material used to inflate the device, by filling the aneurysm sac, will stabilise the endograft and prevent buckling, migration and leaking over time.
- the effects of post-operative changes in the morphology of the aneurysm sac and adjacent blood vessels will also be minimised with improved long-term stability of the repair.
- graft devices of the invention can be deployed without the need for stents, which means that the stent fatigue problem can be avoided.
- the endografts of the invention are primarily intended for planned treatment of aneurysms but may also be used for emergency sealing of a ruptured aneurysm as a holding manoeuvre to stabilise a critically ill patient. Extensions and modifications may be made at a later date using additional inflatable or conventional endografts overlapping within the lumen of the first inflatable endograft using the "trombone technique.
- Inflated devices of the invention can seal aortic side branches and thereby completely isolate an aneurysm from systemic blood pressure.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This invention concerns devices for use in repairing aneurysms, especially of the abdominal aorta.
- An aneurysm occurs when an arterial wall becomes weakened to the extent that the weakened section balloons under pressure from the blood flowing through the artery. An aneurysm can lead to fatality if it ruptures causing rapid loss of blood.
- An aortic aneurysm can be repaired by an endovascular repair procedure, in which a graft is inserted into the aneurysm via the femoral artery effectively to take the blood flow and to isolate the aneurysm. There are three forms of aortic endograft in current usage. The first is a straight stented tube graft. This may be used when there are adequate proximal and distal aortic necks for graft implantation. The tube may be stented at each end for support and to provide pins or hooks for embedding into the arterial wall to secure the tube in place. Alternatively, the tube may be stented throughout its length, such as by means of a metal wire stent. This form of endograft is used most commonly to repair aneurysms of the thoracic aorta.
- An alternative construction of graft is a bifurcated tube for use in a patient with an abdominal aortic aneurysm where there is inadequate distal aortic neck but appropriate iliac artery configurations.
- The third variation of endovascular graft is an aortouniliac graft, in which the tube extends from the proximal aortic neck into one of the iliac arteries. With this configuration an extraanatomic femofemoral bypass graft with a contralateral occlusion device in the common iliac artery is required. This device may be used when significant aneurismal disease is present in the contralateral iliac artery, precluding successful bifurcated graft placement.
- A problem with such grafts is that over time, even over a period of two years, the graft can slip due to wear and tear on the stents, the effect of pulsatile blood flow through the tube and changes in the morphology of the arteries. The blood flow effect can be exaggerated as the graft slips and is able to bend and flex. Thus over time the integrity of the graft and isolation of the aneurysm can be compromised.
- Another problem with stented grafts is that the twisting or flexing of the graft can cause fatigue in the metal stent. Such fatigue leads to fracturing of the stent wire and the resultant wire ends can pierce the graft material. Holes in the graft material mean that the aneurysm is no longer isolated from the blood flow.
- Such grafts are generally used in a planned manner with the graft being selected for a specific patient according to precise pre-operative measurement of the aorta and adjacent arteries. Therefore, such grafts are not readily suited for use in repairing a ruptured aneurysm, where an emergency procedure is required simply to prevent death.
- An object of this invention is to provide a device for use in repairing aneurysms that does not suffer from the above-mentioned disadvantages.
- According to this invention there is provided a device for repairing an aneurysm by deployment within the aneurysm, the device comprising a graft tube, at least part thereof having an inflatable wall, whereby the tube can be deployed in an artery and be inflated to contact at least part of the arterial wall.
- The term arterial wall may include arterial wall that is undamaged and/or aneurysm wall.
- Graft tubes of the invention may be made of any suitable biologically compatible material and especially of plastics material.
- Graft devices of the invention may be straight tubes or bifurcated tubes for use depending on the position and size of the aneurysm, i.e. for deployment in a similar manner to conventional endograft graft tubes. The graft tube of this embodiment may be one that narrows from one end to the other for use in aortouniliac grafting. The device of the invention may have an inflatable wall along its entire length or the device may have one or more discrete inflatable sections, especially at one or more ends of the tube.
- Preferably the inflatable wall of the graft tube has an inner wall and an outer wall that is expandable in preference to the inner wall. The inner wall may be reinforced compared to the outer wall. Reinforcements of the inner wall may be, for example, by means of hoops, cages or mesh. Reinforcements may be of metal or plastics. Suitable metal reinforcement materials include stainless steel and nickel-titanium alloy. Suitable plastics reinforcement materials include inert polymers, such as, for example, polytetrafluoroethylene. Alternatively, the inner wall may be of a different material to the outer wall or may be of the same material but of different thickness to achieve the desired effect of the outer wall expanding upon inflation in preference to the inner wall with the inner wall substantially retaining its shape. The inflatable wall of the tube is preferably inflated by insertion of a settable material. Preferably the material is introduced as a liquid and sets to a solid or semi-solid state. The inflating material used will be biologically compatible and may, for example, be based on collagen or temperature/pH sensitive hydrogels, such as N-isopropyl acrylamide. It is possible that for stented graft tubes the inflating material need only set to a pliable condition. However, if the graft tube of the invention is to be deployed using a balloon to prevent an un-reinforced inner wall collapsing while the inflatable wall is being inflated, the inflating material may need to set to a relatively rigid condition.
- The tube may be deployed in an aneurysm by inflating the tube, so that at least at the proximal artery position and ideally also at the distal artery position the tube grips the walls of the artery where there is no wall damage and between those positions the outer wall of the tube expands to contact the walls of the aneurysm and thereby support the aneurysm against flexing.
- In one embodiment of the invention, a graft tube for use in repairing arterial aneurysms may have a first part with an inflatable wall to fit into the neck of the artery above an aneurysm. The remainder of the graft can be a straight, tapered or bifurcated tube.
- Grafts of the invention may be deployed in an aortic aneurysm by means of conventional endovascular techniques. Typically, a guide wire is inserted through the femoral artery to extend beyond the aneurysm and the graft is guided into position along the wire. A narrow tube for inflating the twin walled part of the graft will be incorporated into the graft, one end of which will be accessible for the purpose of injection within the access wound in the groin. Once inflated to a desired extent the inflation tube is sealed.
- Additionally or alternatively, a graft according to the invention may be deployed with the aid of an inflatable deployment balloon. Thus, a graft of the invention may be positioned in an aneurysm in collapsed form mounted on a deflated deployment balloon. The deployment balloon can then be inflated to seal the graft to the arterial wall above and below the aneurysm before the outer part of the graft is inflated by means of the settable material to conform to the anatomy of the aneurysm. Finally, the deployment balloon is deflated and withdrawn.
- This invention will now be further described, by way of example only, with reference to the accompanying drawings, in which:
-
Figure 1 shows a first prior art aortic aneurysm repair technique; -
Figure 2 shows a second prior art aortic aneurysm repair technique -
Figure 3 shows a third prior art aortic aneurysm repair technique; -
Figure 4 shows a first graft according to the invention; -
Figure 5 shows the graft ofFigure 4 in position in an aortic aneurysm; -
Figure 6 shows a second graft according to the invention in position in an aortic aneurysm; -
Figure 7 shows a third graft according to the invention in position in an aortic aneurysm; -
Figure 8 shows a first stage of deployment of a fourth graft according to the invention; -
Figure 9 shows a second stage in the deployment of the fourth graft according to the invention; -
Figure 10 shows a third stage in the deployment of the fourth graft according to the invention; and -
Figure 11 shows a fourth stage in the deployment of the fourth graft according to the invention. - Referring to
Figure 1 of the accompanying drawings, atubular graft 10 is shown deployed in anaortic aneurysm 12. The aneurysm is situated between proximal anddistal regions aorta 18. This deployment is possible when there is adequate aortic tissue above and below the aneurysm for attachment of the graft. The graft is stented (20,22) at each end and haspins 24 extending from the stented regions for attachment to the aortic wall. - When there is inadequate aortic tissue below an aortic aneurysm for attachment of a graft as shown in
Figure 1 of the drawings, abifurcated graft 30 can be used as shown inFigure 2 . Here the graft is attached in theneck 32 of the aorta above the aneurysm 34 and the twotubes 36 resulting from the bifurcation are each deployed in aniliac artery 38 below the aneurysm. Again the ends of the graft are stented (40) and pins 42 are provided to aid attachment to the artery walls. - If there is significant aneurismal disease in the contralateral iliac artery, which precludes use of a bifurcated graft of the type show in
Figure 2 , agraft 50 as shown inFigure 3 may be used, which is deployed between theaorta 52 above theaneurysm 54 and the healthieriliac artery 56. Thegraft tube 50 narrows to compensate for the difference in widths of the aorta and iliac artery. With this procedure an extraanatomic femofemoral bypass 58 is required with a contralateral occlusion device 60 in the commoniliac artery 62. Again thisgraft 50 is stented at both ends (64,66). - Turning now to
Figures 4 and 5 of the accompanying drawings, there is shown a tubularendovascular graft 100 of the invention for use in repairing an aortic aneurysm. Thegraft 100 is twin-walled having aninner wall 102 and anouter wall 104, whereby thespace 105 between the walls can be inflated by introduction of inflating material. - The
outer wall 104 is relatively expandable compared to theinner wall 102. Both walls may be of the same material but the inner wall reinforced, so that upon inflation, the outer wall expands to contact the aneurysm wall, as shown inFigure 5 , whilst theinner wall 102 retains substantially its diameter, so as not to affect adversely blood flow through the graft. Theinner wall 102 as shown is reinforced withmetal hoops 106, although the reinforcement can be of other materials or take a different form. An alternative may be to make the inner and outer walls of different materials to achieve a similar effect. - The
graft 100 can be deployed in a similar manner to the graft shown inFigure 1 , i.e. between proximal and distal regions 110,112 respectively of theaorta 114 above and below theaneurysm 116. When in position the graft is inflated by introduction of inflating material. This causes the outer wall of the graft to expand, firstly to grip the walls of the artery in those proximal and distal regions to fix the graft in place and secondly to contact the walls of the aneurysm to provide support therefor and, in the case of rupture, to seal the leakage of blood by direct closure of the tear in the aneurysm wall. - The inflating material is preferably a biocompatible material and may, for example, be based on collagen or temperature/pH sensitive hydrogels, such as N-isopropyl acrylamide. Preferably the inflating material is one that can be introduced as a liquid but which sets to form a pliable mass, such as in the nature of a gel. Once sufficient inflating material is introduced into the graft, possibly through a valve, the inflated graft is sealed.
- In
Figure 6 , abifurcated graft 120 is shown which is similar in nature and general use to thegraft 100 ofFigures 4 and 5 but for the type of situation shown inFigure 2 of the drawings, i.e. where there is aortic tissue damage requiring iliac artery deployment. - In
Figure 7 of the accompanying drawings there is shown an alternative form of inflatabletubular graft 150. The graft shown is a bifurcated graft but only atop portion 152 thereof is twin-walled. Thereby thegraft 150 can be deployed and thetop portion 152 inflated as with other embodiments of the invention to fix the graft in theproximal neck 154 of theaorta 156 above theaneurysm 158. The iliac tubes 160,162 of the graft may be fixed in the iliac arteries 164,166 in a conventional manner. - Turning to
figures 8 to 11 of the accompanying drawings, anendograft 200 comprises aninner graft tube 202 and an outerinflatable balloon 204 attached to the inner tube. The endograft shown is bifurcated but it could also be a single stem straight or tapered endograft. The outer balloon is designed to be inflated to conform to the anatomy of an aneurysm. - The
endograft 200 is delivered intoaorta 206 in a collapsed state mounted over aninflatable deployment balloon 208. Once the endograft is in position, the deployment balloon is inflated to expand the graft to form seals at theanastomoses Figure 9 ). With thedeployment balloon 208 still inflated, theouter balloon 204 of the endograft is inflated with a substance that rapidly sets to form asolid mass 216. Once that substance has set, the deployment balloon is deflated and removed, leaving the endograft supported by the inflated outer balloon that has conformed to the contours of theaneurysm sac 218. - Fixation of the endograft can then be enhanced by placement of stents (with or without barbs or hooks), which secure the upper and lower extremities of the graft to the surrounding arterial wall.
- Advantages of grafts according to the invention include the possibility of rapid deployment, which, in the case of a ruptured aneurysm is vital, because the graft does not have to be designed for a particular patient. The ability to inflate the graft to fix it in place means that the same type of graft can be used in a variety of cases. The gel material used to inflate the device, by filling the aneurysm sac, will stabilise the endograft and prevent buckling, migration and leaking over time. The effects of post-operative changes in the morphology of the aneurysm sac and adjacent blood vessels will also be minimised with improved long-term stability of the repair.
- Another possible advantage of graft devices of the invention is that they can be deployed without the need for stents, which means that the stent fatigue problem can be avoided.
- The endografts of the invention are primarily intended for planned treatment of aneurysms but may also be used for emergency sealing of a ruptured aneurysm as a holding manoeuvre to stabilise a critically ill patient. Extensions and modifications may be made at a later date using additional inflatable or conventional endografts overlapping within the lumen of the first inflatable endograft using the "trombone technique.
- Inflated devices of the invention can seal aortic side branches and thereby completely isolate an aneurysm from systemic blood pressure.
Claims (12)
- Apparatus for repairing an aneurysm, comprisinga. a device having an inner graft tube and an inflatable outer balloon attached to an outer surface of said inner graft tube,i. said inner graft tube having an unexpanded condition and said inflatable outer balloon having an uninflated condition allowing deployment of said device in an artery at the location of an aneurysm,ii. said inner graft tube being expandable within the artery to an expanded condition to contact the wall of the artery above and/or below the aneurysm to form a seal with the wall of the artery above and/or below the aneurysm,iii. said outer balloon being inflatable within the aneurysm to an inflated condition with a rapidly settable substance, said outer balloon in said inflated condition filling the aneurysm to support the device; andb. an inflatable deployment balloon having an uninflated condition to fit within said inner graft tube in said unexpanded condition,i. said deployment balloon being inflatable within said inner graft tube to expand said inner graft tube from said unexpanded condition to said expanded condition within the artery and to maintain said inner graft tube in said expanded condition within the artery during inflation of said outer balloon with the rapidly settable substance,ii. said deployment balloon being removable from said inner graft tube upon setting of the rapidly settable substance, whereby said device remains in the artery with said inner graft tube in said expanded condition and said outer balloon in said inflated condition.
- Apparatus according to claim 1, wherein the inner graft tube is a single layer inner graft tube.
- Apparatus according to claim 1 or 2, wherein the inflatable outer balloon is attached to the outer surface of the inner graft tube along a majority of the length of the inner graft tube.
- Apparatus according to claim 1, 2 or 3, wherein the deployment balloon supports the inner graft tube along substantially the entire length of the inner graft tube.
- Apparatus according to any preceding claim, wherein the inflatable outer balloon is attached to the outer surface of the inner graft tube around the circumference of the inner graft tube.
- Apparatus according to any preceding claim, wherein the apparatus comprises a plurality of inflatable outer balloons attached to the outer surface of the inner graft tube.
- Apparatus according to any preceding claim, wherein the apparatus further comprises one or more stents that can be placed to further secure the inner graft tube to the wall of the artery above and/or below the aneurysm so as to enhance the seal between the inner graft tube and the wall of the artery above and/or below the aneurysm.
- Apparatus according to any preceding claim, wherein the inner graft tube is a straight, tapered or bifurcated tube.
- Apparatus according to any preceding claim, wherein the rapidly settable substance is introduced into the outer balloon via a tube incorporated into the device.
- Apparatus according to any preceding claim, wherein the rapidly settable substance is introduced into the outer balloon as a liquid and rapidly sets to a solid or semi-solid state.
- Apparatus according to any preceding claim, wherein the rapidly settable substance comprises collagen or a temperature/pH sensitive hydrogel.
- Apparatus according to claim 11, wherein the hydrogel is N-isopropyl or acrylamide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0114918.6A GB0114918D0 (en) | 2001-06-19 | 2001-06-19 | Devices for repairing aneurysms |
EP02730505.1A EP1397089B1 (en) | 2001-06-19 | 2002-06-17 | Devices for repairing aneurysms |
Related Parent Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02730505.1 Division | 2002-06-17 | ||
EP02730505.1A Division EP1397089B1 (en) | 2001-06-19 | 2002-06-17 | Devices for repairing aneurysms |
EP02730505.1A Division-Into EP1397089B1 (en) | 2001-06-19 | 2002-06-17 | Devices for repairing aneurysms |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2260795A2 true EP2260795A2 (en) | 2010-12-15 |
EP2260795A3 EP2260795A3 (en) | 2013-04-17 |
EP2260795B1 EP2260795B1 (en) | 2016-05-25 |
Family
ID=9916894
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10011024.6A Expired - Lifetime EP2260795B1 (en) | 2001-06-19 | 2002-06-17 | Devices for repairing aneurysms |
EP02730505.1A Expired - Lifetime EP1397089B1 (en) | 2001-06-19 | 2002-06-17 | Devices for repairing aneurysms |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02730505.1A Expired - Lifetime EP1397089B1 (en) | 2001-06-19 | 2002-06-17 | Devices for repairing aneurysms |
Country Status (5)
Country | Link |
---|---|
US (3) | US7682383B2 (en) |
EP (2) | EP2260795B1 (en) |
AU (1) | AU2002302823C1 (en) |
GB (1) | GB0114918D0 (en) |
WO (1) | WO2002102282A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108403257A (en) * | 2014-05-30 | 2018-08-17 | 安德乐吉克斯公司 | Use the modular rack implant system and method for expansion type interstitital texture |
Families Citing this family (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020022860A1 (en) | 2000-08-18 | 2002-02-21 | Borillo Thomas E. | Expandable implant devices for filtering blood flow from atrial appendages |
GB0114918D0 (en) * | 2001-06-19 | 2001-08-08 | Vortex Innovation Ltd | Devices for repairing aneurysms |
AUPR847201A0 (en) * | 2001-10-26 | 2001-11-15 | Cook Incorporated | Endoluminal graft |
US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
EP1542616B1 (en) | 2002-09-20 | 2015-04-22 | Endologix, Inc. | Stent-graft with positioning anchor |
US7481821B2 (en) | 2002-11-12 | 2009-01-27 | Thomas J. Fogarty | Embolization device and a method of using the same |
US20040260382A1 (en) | 2003-02-12 | 2004-12-23 | Fogarty Thomas J. | Intravascular implants and methods of using the same |
US20050015110A1 (en) | 2003-07-18 | 2005-01-20 | Fogarty Thomas J. | Embolization device and a method of using the same |
EP2526899B1 (en) | 2003-12-23 | 2014-01-29 | Sadra Medical, Inc. | Repositionable heart valve |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7988724B2 (en) | 2003-12-23 | 2011-08-02 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7534259B2 (en) | 2004-05-05 | 2009-05-19 | Direct Flow Medical, Inc. | Nonstented heart valves with formed in situ support |
EP2422745B1 (en) | 2004-07-22 | 2014-04-02 | Endologix, Inc. | Systems for endovascular aneurysm treatment |
US8048145B2 (en) | 2004-07-22 | 2011-11-01 | Endologix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US20060222596A1 (en) | 2005-04-01 | 2006-10-05 | Trivascular, Inc. | Non-degradable, low swelling, water soluble radiopaque hydrogel polymer |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
JP5070373B2 (en) * | 2005-04-28 | 2012-11-14 | エンドーロジックス インコーポレイテッド | Graft system having a filling structure supported by a framework and method of use thereof |
EP1887983A4 (en) * | 2005-06-07 | 2008-12-17 | Direct Flow Medical Inc | Stentless aortic valve replacement with high radial strength |
US20060287668A1 (en) * | 2005-06-16 | 2006-12-21 | Fawzi Natalie V | Apparatus and methods for intravascular embolic protection |
CA2614203A1 (en) | 2005-07-07 | 2007-01-18 | Nellix, Inc. | Systems and methods for endovascular aneurysm treatment |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US20070150041A1 (en) | 2005-12-22 | 2007-06-28 | Nellix, Inc. | Methods and systems for aneurysm treatment using filling structures |
WO2007127433A2 (en) * | 2006-04-28 | 2007-11-08 | Medtronic, Inc. | Method and apparatus for cardiac valve replacement |
US7790273B2 (en) * | 2006-05-24 | 2010-09-07 | Nellix, Inc. | Material for creating multi-layered films and methods for making the same |
US7872068B2 (en) | 2006-05-30 | 2011-01-18 | Incept Llc | Materials formable in situ within a medical device |
BRPI0602736A (en) | 2006-06-06 | 2008-01-29 | Luiz Gonzaga Granja Jr | inflatable anastomosis prosthesis |
US7935144B2 (en) | 2006-10-19 | 2011-05-03 | Direct Flow Medical, Inc. | Profile reduction of valve implant |
US8133213B2 (en) | 2006-10-19 | 2012-03-13 | Direct Flow Medical, Inc. | Catheter guidance through a calcified aortic valve |
US20080188923A1 (en) * | 2007-02-01 | 2008-08-07 | Jack Fa-De Chu | Endovascular devices to protect aneurysmal wall |
US20080228259A1 (en) * | 2007-03-16 | 2008-09-18 | Jack Fa-De Chu | Endovascular devices and methods to protect aneurysmal wall |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
CA2978267A1 (en) | 2007-08-23 | 2009-02-23 | Dfm, Llc | Translumenally implantable heart valve with formed in place support |
US7862538B2 (en) * | 2008-02-04 | 2011-01-04 | Incept Llc | Surgical delivery system for medical sealant |
WO2009103011A1 (en) * | 2008-02-13 | 2009-08-20 | Nellix, Inc. | Graft endoframe having axially variable characteristics |
WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
CA2721950A1 (en) | 2008-04-25 | 2009-10-29 | Nellix, Inc. | Stent graft delivery system |
WO2009149294A1 (en) | 2008-06-04 | 2009-12-10 | Nellix, Inc. | Sealing apparatus and methods of use |
EP2299933A4 (en) | 2008-06-04 | 2015-07-29 | Endologix Inc | Docking apparatus and methods of use |
CA2739961A1 (en) | 2008-10-10 | 2010-04-15 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
WO2010127305A2 (en) | 2009-05-01 | 2010-11-04 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
EP2459127B1 (en) | 2009-07-27 | 2015-09-23 | Endologix, Inc. | Stent graft |
US20110276078A1 (en) * | 2009-12-30 | 2011-11-10 | Nellix, Inc. | Filling structure for a graft system and methods of use |
US9603708B2 (en) | 2010-05-19 | 2017-03-28 | Dfm, Llc | Low crossing profile delivery catheter for cardiovascular prosthetic implant |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
WO2012032187A1 (en) | 2010-09-10 | 2012-03-15 | Symetis Sa | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
US8961501B2 (en) | 2010-09-17 | 2015-02-24 | Incept, Llc | Method for applying flowable hydrogels to a cornea |
US9566149B2 (en) | 2010-11-16 | 2017-02-14 | W. L. Gore & Associates, Inc. | Devices and methods for in situ fenestration of a stent-graft at the site of a branch vessel |
WO2012068298A1 (en) | 2010-11-17 | 2012-05-24 | Endologix, Inc. | Devices and methods to treat vascular dissections |
US8801768B2 (en) | 2011-01-21 | 2014-08-12 | Endologix, Inc. | Graft systems having semi-permeable filling structures and methods for their use |
WO2012112749A2 (en) * | 2011-02-18 | 2012-08-23 | Sequent Medical, Inc. | Blood flow disruption devices and methods for the treatment of vascular defects |
EP2688516B1 (en) | 2011-03-21 | 2022-08-17 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
CN103648437B (en) | 2011-04-06 | 2016-05-04 | 恩朵罗杰克斯国际控股有限公司 | For the method and system of vascular aneurysms treatment |
EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
CA2835893C (en) | 2011-07-12 | 2019-03-19 | Boston Scientific Scimed, Inc. | Coupling system for medical devices |
US9131926B2 (en) | 2011-11-10 | 2015-09-15 | Boston Scientific Scimed, Inc. | Direct connect flush system |
US8940014B2 (en) | 2011-11-15 | 2015-01-27 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US9510945B2 (en) | 2011-12-20 | 2016-12-06 | Boston Scientific Scimed Inc. | Medical device handle |
US9277993B2 (en) | 2011-12-20 | 2016-03-08 | Boston Scientific Scimed, Inc. | Medical device delivery systems |
WO2013112547A1 (en) | 2012-01-25 | 2013-08-01 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
US9445897B2 (en) | 2012-05-01 | 2016-09-20 | Direct Flow Medical, Inc. | Prosthetic implant delivery device with introducer catheter |
US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
US10201638B2 (en) | 2013-03-14 | 2019-02-12 | Endologix, Inc. | Systems and methods for forming materials in situ within a medical device |
US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
JP6645979B2 (en) | 2014-03-07 | 2020-02-14 | エンドーロジックス インコーポレイテッド | Improved method of forming hydrogels and materials thereof |
US11439396B2 (en) | 2014-05-02 | 2022-09-13 | W. L. Gore & Associates, Inc. | Occluder and anastomosis devices |
US10363040B2 (en) * | 2014-05-02 | 2019-07-30 | W. L. Gore & Associates, Inc. | Anastomosis devices |
US11712230B2 (en) | 2014-05-02 | 2023-08-01 | W. L. Gore & Associates, Inc. | Occluder and anastomosis devices |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
US10869755B2 (en) | 2014-12-09 | 2020-12-22 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US10449043B2 (en) | 2015-01-16 | 2019-10-22 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
WO2016126524A1 (en) | 2015-02-03 | 2016-08-11 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having tubular seal |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
EP3632378B1 (en) | 2015-05-01 | 2024-05-29 | JenaValve Technology, Inc. | Device with reduced pacemaker rate in heart valve replacement |
EP3294220B1 (en) | 2015-05-14 | 2023-12-06 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
WO2016183526A1 (en) | 2015-05-14 | 2016-11-17 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
WO2017004377A1 (en) | 2015-07-02 | 2017-01-05 | Boston Scientific Scimed, Inc. | Adjustable nosecone |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
US10779940B2 (en) | 2015-09-03 | 2020-09-22 | Boston Scientific Scimed, Inc. | Medical device handle |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
US10188500B2 (en) * | 2016-02-12 | 2019-01-29 | Medtronic Vascular, Inc. | Stent graft with external scaffolding and method |
CN109475419B (en) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | Heart valve prosthesis delivery systems and methods for delivering heart valve prostheses through guide sheaths and loading systems |
US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
CN109310494A (en) * | 2016-05-13 | 2019-02-05 | 恩朵罗杰克斯股份有限公司 | System and method with transplant, inflatable filling channel and interstitital texture |
US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
EP3471665B1 (en) | 2016-06-17 | 2023-10-11 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices |
CN109475402A (en) * | 2016-06-21 | 2019-03-15 | 美敦力瓦斯科尔勒公司 | The vascular endoprostheses of coating for aneurysm treatment |
AU2018203053B2 (en) | 2017-01-23 | 2020-03-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CR20190381A (en) | 2017-01-23 | 2019-09-27 | Cephea Valve Tech Inc | Replacement mitral valves |
JP7094965B2 (en) | 2017-01-27 | 2022-07-04 | イエナバルブ テクノロジー インク | Heart valve imitation |
US11724075B2 (en) | 2017-04-18 | 2023-08-15 | W. L. Gore & Associates, Inc. | Deployment constraining sheath that enables staged deployment by device section |
WO2018226915A1 (en) | 2017-06-08 | 2018-12-13 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
EP3661458A1 (en) | 2017-08-01 | 2020-06-10 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
US10939996B2 (en) | 2017-08-16 | 2021-03-09 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
JP7047106B2 (en) | 2018-01-19 | 2022-04-04 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Medical device delivery system with feedback loop |
EP3740160A2 (en) | 2018-01-19 | 2020-11-25 | Boston Scientific Scimed Inc. | Inductance mode deployment sensors for transcatheter valve system |
WO2019157156A1 (en) | 2018-02-07 | 2019-08-15 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
WO2019165394A1 (en) | 2018-02-26 | 2019-08-29 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
CN112399836A (en) | 2018-05-15 | 2021-02-23 | 波士顿科学国际有限公司 | Replacement heart valve commissure assemblies |
US11241310B2 (en) | 2018-06-13 | 2022-02-08 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
US11241312B2 (en) | 2018-12-10 | 2022-02-08 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
CA3133857A1 (en) | 2019-03-20 | 2020-09-24 | inQB8 Medical Technologies, LLC | Aortic dissection implant |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
EP4169469A1 (en) | 2021-10-25 | 2023-04-26 | Erbe Vision GmbH | Laparoskopic camera arrangement and method for camera alignment error correction |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8927282D0 (en) * | 1989-12-01 | 1990-01-31 | Univ Strathclyde | Vascular surgical devices |
US5122154A (en) | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
AU1091095A (en) * | 1993-11-08 | 1995-05-29 | Harrison M. Lazarus | Intraluminal vascular graft and method |
US5534024A (en) * | 1994-11-04 | 1996-07-09 | Aeroquip Corporation | Intraluminal stenting graft |
US5785679A (en) * | 1995-07-19 | 1998-07-28 | Endotex Interventional Systems, Inc. | Methods and apparatus for treating aneurysms and arterio-venous fistulas |
US5769882A (en) * | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
US5665117A (en) * | 1995-11-27 | 1997-09-09 | Rhodes; Valentine J. | Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use |
US5871537A (en) * | 1996-02-13 | 1999-02-16 | Scimed Life Systems, Inc. | Endovascular apparatus |
US5827321A (en) * | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
GB9904722D0 (en) * | 1999-03-03 | 1999-04-21 | Murch Clifford R | A tubular intraluminal graft |
US6312462B1 (en) * | 1999-09-22 | 2001-11-06 | Impra, Inc. | Prosthesis for abdominal aortic aneurysm repair |
AUPQ302899A0 (en) * | 1999-09-23 | 1999-10-21 | Endogad Research Pty Limited | Implants for the use in the treatment of aneurysmal disease |
US6312463B1 (en) * | 2000-02-01 | 2001-11-06 | Endotex Interventional Systems, Inc. | Micro-porous mesh stent with hybrid structure |
ATE255860T1 (en) * | 2000-03-03 | 2003-12-15 | Cook Inc | ENDOVASCULAR DEVICE WITH STENT |
US20020026217A1 (en) * | 2000-04-26 | 2002-02-28 | Steven Baker | Apparatus and method for repair of perigraft flow |
GB0114918D0 (en) | 2001-06-19 | 2001-08-08 | Vortex Innovation Ltd | Devices for repairing aneurysms |
US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
US7338511B2 (en) * | 2002-05-24 | 2008-03-04 | Boston Scientific-Scimed, Inc. | Solid embolic material with variable expansion |
US7481821B2 (en) | 2002-11-12 | 2009-01-27 | Thomas J. Fogarty | Embolization device and a method of using the same |
EP2422745B1 (en) | 2004-07-22 | 2014-04-02 | Endologix, Inc. | Systems for endovascular aneurysm treatment |
-
2001
- 2001-06-19 GB GBGB0114918.6A patent/GB0114918D0/en not_active Ceased
-
2002
- 2002-06-17 EP EP10011024.6A patent/EP2260795B1/en not_active Expired - Lifetime
- 2002-06-17 AU AU2002302823A patent/AU2002302823C1/en not_active Ceased
- 2002-06-17 US US10/481,386 patent/US7682383B2/en not_active Expired - Fee Related
- 2002-06-17 EP EP02730505.1A patent/EP1397089B1/en not_active Expired - Lifetime
- 2002-06-17 WO PCT/GB2002/002750 patent/WO2002102282A1/en active Search and Examination
-
2009
- 2009-11-12 US US12/616,928 patent/US8814928B2/en not_active Expired - Fee Related
-
2014
- 2014-07-14 US US14/330,812 patent/US10743979B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
None |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108403257A (en) * | 2014-05-30 | 2018-08-17 | 安德乐吉克斯公司 | Use the modular rack implant system and method for expansion type interstitital texture |
Also Published As
Publication number | Publication date |
---|---|
US20040204755A1 (en) | 2004-10-14 |
US8814928B2 (en) | 2014-08-26 |
EP2260795A3 (en) | 2013-04-17 |
GB0114918D0 (en) | 2001-08-08 |
EP2260795B1 (en) | 2016-05-25 |
US20100131040A1 (en) | 2010-05-27 |
EP1397089A1 (en) | 2004-03-17 |
WO2002102282A1 (en) | 2002-12-27 |
US7682383B2 (en) | 2010-03-23 |
US20150012081A1 (en) | 2015-01-08 |
US10743979B2 (en) | 2020-08-18 |
AU2002302823C1 (en) | 2008-05-29 |
EP1397089B1 (en) | 2017-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10743979B2 (en) | Apparatus and methods for repairing aneurysms | |
AU2002302823B2 (en) | Devices for repairing aneurysms | |
AU2002302823A1 (en) | Devices for repairing aneurysms | |
US11497597B2 (en) | Modular stent graft systems and methods with inflatable fill structures | |
US6706064B1 (en) | Expandable device | |
US5693088A (en) | Intraluminal vascular graft | |
US7468072B2 (en) | Endovascular balloon graft | |
EP1176926B1 (en) | Inflatable intraluminal graft | |
US8182525B2 (en) | Methods and systems for endovascular aneurysm treatment | |
US5709701A (en) | Apparatus for implanting a prothesis within a body passageway | |
US7108715B2 (en) | Endoluminal graft | |
US6428565B1 (en) | System and method for edoluminal grafting of bifurcated or branched vessels | |
EP0903119B1 (en) | Apparatus for repairing an abdominal aortic aneurysm | |
US5632763A (en) | Bifurcated stent and method for implanting same | |
WO1998055047A1 (en) | Inflatable intraluminal stent and method for affixing same within the human body | |
EP3733129A1 (en) | Dual inflatable arterial prosthesis | |
US20220047374A1 (en) | Stent graft systems and methods with inflatable fill structure and fillable cuff | |
US20190008631A1 (en) | Systems and methods with fenestrated graft and filling structure | |
US11723668B2 (en) | Systems and methods with anchor device for fixation of filling structures in blood vessels | |
AU2007284360A1 (en) | Balloon for stent member | |
US20210401566A1 (en) | Stent graft systems and methods with cuff and limb | |
AU699279B2 (en) | Balloon device for use in repairing an abdominal aortic aneurysm | |
AU2002363226A1 (en) | Endoluminal graft |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 1397089 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ROBIN, MARIE THERESE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVOTEK INNOVATION LIMITED |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61F 2/07 20130101AFI20130314BHEP |
|
17P | Request for examination filed |
Effective date: 20131003 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
17Q | First examination report despatched |
Effective date: 20150609 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ENDOLOGIX, INC. |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 60248100 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61F0002060000 Ipc: A61F0002890000 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61F 2/945 20130101ALI20151027BHEP Ipc: A61F 2/89 20130101AFI20151027BHEP Ipc: A61F 2/07 20130101ALI20151027BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20151216 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 1397089 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Ref country code: AT Ref legal event code: REF Ref document number: 801613 Country of ref document: AT Kind code of ref document: T Effective date: 20160615 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 60248100 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20160525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 801613 Country of ref document: AT Kind code of ref document: T Effective date: 20160525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160926 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160826 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 60248100 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160630 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160630 |
|
26N | No opposition filed |
Effective date: 20170228 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 16 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160617 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160525 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160617 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20200512 Year of fee payment: 19 Ref country code: DE Payment date: 20200602 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20200610 Year of fee payment: 19 Ref country code: IT Payment date: 20200512 Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60248100 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20210617 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210617 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210617 |